Skip to main content

Nasdaq IPOs

Updated: Renaissance Capital's 2020 US IPO Market Review

5 years 8 months ago
The IPO Market Has the Best of Times in the Worst of Times 2020 was a year to forget for many people, but it was unforgettable for IPO investors who benefitted from both the number of IPOs and their outsized average returns. While the COVID-19 pandemic sent global markets into a
Renaissance Capital

Medical device maker Cardiva Medical files for a $75 million IPO

5 years 8 months ago
Cardiva Medical, which makes minimally invasive catheter-based vascular closure devices, filed on Monday with the SEC to raise up to $75 million in an initial public offering. Cardiva's devices are designed around an easy to use, catheter-based delivery system and the natural cl
Renaissance Capital

Medical device maker Cardiva Medical files for a $75 million IPO

5 years 8 months ago
Cardiva Medical, which makes minimally invasive catheter-based vascular closure devices, filed on Monday with the SEC to raise up to $75 million in an initial public offering. Cardiva's devices are designed around an easy to use, catheter-based delivery system and the natural cl
Renaissance Capital

Oncology biotech Cullinan Management sets terms for $150 million IPO

5 years 8 months ago
Cullinan Management, a Phase 1/2a biotech developing and investing in oncology therapies, announced terms for its IPO on Monday. The Cambridge, MA-based company plans to raise $150 million by offering 8.3 million shares at a price range of $17 to $19. Existing shareholders
Renaissance Capital

Oncology biotech Cullinan Oncology sets terms for $150 million IPO

5 years 8 months ago
Cullinan Oncology, a Phase 1 biotech developing targeted oncology and immuno-oncology therapies, announced terms for its IPO on Monday. The Cambridge, MA-based company plans to raise $150 million by offering 8.3 million shares at a price range of $17 to $19. At the midpoint of t
Renaissance Capital
Checked
29 minutes 5 seconds ago
This feed is responsible for generating the rss feed related to the topic IPOs
Subscribe to Nasdaq IPOs feed